Govt Job for Ph.D, M.Pharm, M.Sc as Research Associate at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

A Research Associate is required in the research project entitled, “Development of personalized radiation treatment regime using Radio-genomics based radiation toxicity prediction model in Head Neck Squamous Cell Carcinoma (HNSCC)” funded by ICMR, New Delhi in Department of Biochemistry, PGIMER, Chandigarh.

Post : Research Associate

Essential qualification :PhD / MD / MS or Equivalent degree or having 3 years of research and/or teaching with at least one research paper in Science Citation Indexed (SCI) journal
Age : As per ICMR rules (Relaxation will be given to women/SC/ST/OBC/PWD candidates as per rules)
Desirable : Experience in NGS data analysis and Statistical methods for developing risk prediction models

Salary/Stipend : Rs. 47,000/- + HRA @16% i.e. Rs. 7,520 p.m
Tenure : Initially for 1 year to be extended till the tenure of the project subject to the performance of the candidate

Interested candidates are requested to send detailed CV to the undersigned through e-mail ID: Iab320pgi@gmail.com.
Online interview : Shortlisted candidates will be intimated through e-mail. Interview will be on Zoom/Google meet platform

Last date of submission of CV :June 9, 2021

Related Posts

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs